Authors:
Larsen, SW
Rinvar, E
Svendsen, O
Lykkesfeldt, J
Friis, GJ
Larsen, C
Citation: Sw. Larsen et al., Determination of the disappearance rate of iodine-125 labelled oils from the injection site after intramuscular and subcutaneous administration to pigs, INT J PHARM, 230(1-2), 2001, pp. 67-75
Authors:
Larsen, SW
Thomsen, AE
Rinvar, E
Friis, GJ
Larsen, C
Citation: Sw. Larsen et al., Effect of drug lipophilicity on in vitro release rate from oil vehicles using nicotinic acid esters as model prodrug derivatives, INT J PHARM, 216(1-2), 2001, pp. 83-93
Authors:
Fredholt, K
Adrian, C
Just, L
Larsen, DH
Weng, SS
Moss, B
Friis, GJ
Citation: K. Fredholt et al., Chemical and enzymatic stability as well as transport properties of a Leu-enkephalin analogue and ester prodrugs thereof, J CONTR REL, 63(3), 2000, pp. 261-273
Authors:
Bak, A
Siahaan, TJ
Gudmundsson, OS
Gangwar, S
Friis, GJ
Borchardt, RT
Citation: A. Bak et al., Synthesis and evaluation of the physicochemical properties of esterase-sensitive cyclic prodrugs of opioid peptides using an (acyloxy)alkoxy linker, J PEPT RES, 53(4), 1999, pp. 393-402
Authors:
Lepist, EI
Ostergaard, J
Fredholt, K
Lennernas, H
Friis, GJ
Citation: Ei. Lepist et al., Stability and perfusion studies of Desmopressin (dDAVP) and prodrugs in the rat jejunum, EXP TOX PAT, 51(4-5), 1999, pp. 363-368
Authors:
Bak, A
Fich, M
Larsen, BD
Frokjaer, S
Friis, GJ
Citation: A. Bak et al., N-terminal 4-imidazolidinone prodrugs of Leu-enkephalin: synthesis, chemical and enzymatic stability studies, EUR J PH SC, 7(4), 1999, pp. 317-323
Authors:
Bak, A
Gudmundsson, OS
Friis, GJ
Siahaan, TJ
Borchardt, RT
Citation: A. Bak et al., Acyloxyalkoxy-based cyclic prodrugs of opioid peptides: Evaluation of the chemical and enzymatic stability as well as their transport properties across Caco-2 cell monolayers, PHARM RES, 16(1), 1999, pp. 24-29
Authors:
Fredholt, K
Ostergaard, J
Savolainen, J
Friis, GJ
Citation: K. Fredholt et al., alpha-chymotrypsin-catalyzed degradation of desmopressin (dDAVP): influence of pH, concentration and various cyclodextrins, INT J PHARM, 178(2), 1999, pp. 223-229